fenoldopam has been researched along with Benign Neoplasms in 1 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "D." | 1.33 | Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent. ( Finkel, K; Gubert, M; Johnson, T; Samuels, J; Shaw, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samuels, J | 1 |
| Finkel, K | 1 |
| Gubert, M | 1 |
| Johnson, T | 1 |
| Shaw, A | 1 |
1 other study available for fenoldopam and Benign Neoplasms
| Article | Year |
|---|---|
Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent.
Topics: Acute Kidney Injury; Adult; Aged; Critical Illness; Dopamine Agonists; Dose-Response Relationship, D | 2005 |